CMS Changes Status Indicator for 0343U (MIR Sentinel Prostate Cancer Test, urine, risk of prostate cancer.

miR Sentinel is a MAAA prostate cancer risk test based on urine exosomes for 442 small noncoding RNAs. It's code 0343U.

In the hospital outpatient system, CMS assigned it to status E1, which is not paid by Medicare on any outpatient claim type.   The status is updated to A which is simply a genomic lab test not paid under the OPPS (APC) system.  (It's paid under the CLFS system and payable since it is a human genetic test, so not bundled). See CR13031, 12/8/2022, T11737.  A table on page 30 shows the "A" is effective backwards to October 1, 2022.

https://www.cms.gov/files/document/r11737cp.pdf

It's cryptic why it was assigned to "E1" at all, unless it was confused with a type of PSA test that isn't covered, so therefore, E1.